Company Medovex Corp OTC Bulletin Board
Equities
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
||
- USD | - |
|
Business Summary
Sales per Business
USD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Biologics and Therapeutic Device Incubator
100.0
%
| 2 | 100.0 % | 0 | 100.0 % | -71.86% |
Sales per region
USD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 2 | 100.0 % | 0 | 100.0 % | -71.86% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 53 | 19-01-07 | |
Jeremy Daniel
DFI | Director of Finance/CFO | 48 | 19-02-03 |
Tanya Rhodes
CTO | Chief Tech/Sci/R&D Officer | 64 | 20-06-14 |
Jason Assad
IRC | Investor Relations Contact | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 65 | 22-01-16 | |
Chief Executive Officer | 53 | 19-01-07 | |
Chairman | 77 | 19-01-07 | |
Matthew Anderer
BRD | Director/Board Member | 59 | 22-01-16 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 712,710 | 253,876 ( 35.62 %) | 0 | 35.62 % |
Company contact information
![address Medovex Corp](https://cdn.zonebourse.com/static/address/38766630.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+4.57% | 212B | |
+8.61% | 187B | |
+26.34% | 155B | |
+33.90% | 115B | |
+2.17% | 65.5B | |
+14.50% | 52.87B | |
-3.30% | 45.25B | |
-3.98% | 39.7B | |
+6.66% | 37.72B |
- Stock Market
- Equities
- IVRN Stock
- Stock
- Company Medovex Corp